Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-064540)

Filing Details

Accession Number:: 0001209191-21-064540
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-15 17:59:52
Reporting Period:: 2021-11-15

Accepted Time:: 2021-11-15 17:59:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Viracta Therapeutics Inc.	VIRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1026765	Ivor Royston	C/O Viracta Therapeutics, Inc. 2533 S Coast Hwy 101, Suite 210 Cardiff CA 92007	Ceo & President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-15	8,000	$5.56	548,599	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,599	Indirect	By spouse